France OKs sale of medical cannabis

France OKs sale of medical cannabis

The French drug safety agency has approved commercial sales of a medicine derived from cannabis for the first time in France.

ReadMore about dagga (cannabis)

France’s Health Ministry has said in a statement that sales of Sativex, produced by Britain’s GW Pharmaceuticals, will be allowed for the treatment of muscle spasms associated with multiple sclerosis.

Sativex contains marijuana’s two best known components – delta 9-THC and cannabidiol. The company’s website says the medicine has already been launched in 11 countries and approved in more than a dozen others.

A number of countries have been easing curbs on the sale of cannabis-based products for medical use in recent years, and the US state of Colorado allowed the nation’s first legal recreational marijuana shops to open starting this year.

Our Facebook page Comments


We are proud to announce that MEDLINES – Healthcare headlines started its’ very own blog site. Our mission is to bring the very best of the news and newsworthy issues of the medical field, from university news to business and tech info.

Leave a Reply